Home > Healthcare > Medical Devices > Therapeutic Devices > Diabetes Care Devices Market

Diabetes Care Devices Market Share

  • Report ID: GMI3250
  • Published Date: Feb 2024
  • Report Format: PDF

Diabetes Care Devices Market Share

The diabetes care devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Becton, Dickinson and Company, Medtronic plc, among others have a notable presence in the market.
 

Diabetes Care Devices Market Companies

Some of the eminent market participants operating in the diabetes care devices industry include:

  • Abbott Laboratories
  • Arkray, Inc.
  • Ascensia Diabetes Care Holding AG
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Bionime Corporation
  • DarioHealth Corp.
  • Dexcom, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • LifeScan, Inc.
  • Medtronic plc
  • Nova Biomedical, Inc.
  • Novo Nordisk A/S
  • Pendiq GmBH
  • Sanofi
  • Sinocare, Inc.
  • Tandem Diabetes Care Inc.
  • Ypsomed AG
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global diabetes care devices industry was valued at around USD 46.1 billion in 2023 and is estimated to reach over USD 107.2 billion by 2032 due to the growing prevalence of diabetes across the world.

The blood glucose monitoring devices segment will record 9.9% CAGR during 2024-2032, attributed to the adoption of CGM systems for continuous and real-time monitoring of glucose levels to ensure optimal care to diabetes patients.

North America diabetes care devices industry accounted for USD 18.6 billion in 2023 and is predicted to witness substantial growth through 2032 due to the ongoing advancements in technology, including the integration of smart features, connectivity, and data-sharing capabilities in medical devices.

Abbott Laboratories, Arkray, Inc., Ascensia Diabetes Care Holding AG, B. Braun Melsungen AG, Becton Dickinson and Company, Bionime Corporation, DarioHealth Corp., Dexcom, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Insulet Corporation, LifeScan, Inc., Medtronic plc, Nova Biomedical, Inc., Novo Nordisk A/S, Pendiq GmBH, Sanofi, Sinocare, Inc., Tandem Diabetes Care Inc., and Ypsomed AG.

Diabetes Care Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 21
  • Tables & Figures: 606
  • Countries covered: 37
  • Pages: 257
 Download Free Sample